Workflow
从无到有,成都国际铁路港综合保税区实现医药冷链全链条服务
Sou Hu Cai Jing·2025-05-30 14:26

Core Insights - Chengdu International Railway Port Comprehensive Bonded Zone has achieved a milestone in the development of the pharmaceutical cold chain industry with Sichuan Lepu Kang Pharmaceutical Co., Ltd. obtaining a medical device business license, becoming the first bonded pharmaceutical enterprise in the zone with dual GSP certification for both drugs and medical devices [1][3] Group 1: Industry Development - The successful acquisition of GSP dual certification signifies a leap from non-existence to a fully functional pharmaceutical cold chain capability in the Chengdu International Railway Port Comprehensive Bonded Zone [1][4] - This development establishes a standardized, professional service capacity for pharmaceutical and medical device products, laying a solid foundation for creating a regionally influential pharmaceutical cold chain distribution center [1][4] Group 2: Regulatory and Operational Framework - GSP (Good Supply Practice) is a critical standard in the pharmaceutical industry that ensures the quality and safety of drugs and medical devices during circulation [3] - Lepu Kang has established a comprehensive and compliant management system across the entire supply chain, including procurement, storage, transportation, and sales, enabling the management of multiple categories and temperature zones of pharmaceutical products [3] Group 3: Future Prospects - The breakthrough in GSP dual certification not only enhances the company's qualifications but also represents an important practice in policy innovation within the bonded zone [4] - The development is expected to fill the gap in regional pharmaceutical bonded cold chain services, attracting more leading pharmaceutical companies and creating an industrial cluster effect [4] - The bonded zone plans to deepen its "bonded +" functions, expanding into pharmaceutical research and international distribution services, facilitating the transformation of Qingbaijiang from a traditional logistics hub to a high-value pharmaceutical supply chain center [4]